Renal Cancers Completed Phase 0 Trials for Sorafenib (DB00398)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Completed0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00405366Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney CancerTreatment